GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 516.35M
Enterprise Value 36.42M
Trailing P/E -2.04
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)39.18
Price/Book (mrq)2.04
Enterprise Value/Revenue 315.39
Enterprise Value/EBITDA 6-1.05

Financial Highlights

Fiscal Year
Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-1,542.00%
Management Effectiveness
Return on Assets (ttm)-39.35%
Return on Equity (ttm)-74.83%
Income Statement
Revenue (ttm)417.35k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-65.40%
Gross Profit (ttm)60.7k
EBITDA -6.14M
Net Income Avi to Common (ttm)-6.76M
Diluted EPS (ttm)-0.45
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)8.85M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.94
Book Value Per Share (mrq)0.45
Cash Flow Statement
Operating Cash Flow (ttm)-5.48M
Levered Free Cash Flow (ttm)-3.48M

Trading Information

Stock Price History
Beta 3.78
52-Week Change 3-39.54%
S&P500 52-Week Change 319.65%
52 Week High 32.89
52 Week Low 30.70
50-Day Moving Average 30.89
200-Day Moving Average 30.94
Share Statistics
Avg Vol (3 month) 3157.84k
Avg Vol (10 day) 3192.99k
Shares Outstanding 5N/A
Float 13.64M
% Held by Insiders 10.00%
% Held by Institutions 10.37%
Shares Short 3721.91k
Short Ratio 312.11
Short % of Float 30.00%
Shares Short (prior month) 3785.87k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/5
Last Split Date 3Jan 20, 2015